# US 2002/0160983 A1 · Substituted benzopyranones as telomerase inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0160983 A1
- Document ID: US20020160983A1
- Status: Published application
- Kind: A1
- Application number: 09/812,120
- Filed: 2001-03-16
- Published: 2002-10-31
- Earliest claimed: 2001-03-16
- Inventors: Alberto Bargiotti; Luisella Bonomini; Maria Menichincheri; Jurgen Moll; Paolo Polucci; Chiara Soncini; Ermes Vanotti
- Web page: https://patentgrep.com/patent/US20020160983A1

## CPC

- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 311/30: not hydrogenated in the hetero ring, e.g. flavones
- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to benzopyranone derivatives, to methods for treating telomerase-modulated diseases, in particular cancers, with said derivatives, to a process for their preparation, to their use as medicaments and to pharmaceutical compositions comprising them.

## Claims

### Claim 1

A method for inhibiting telomerase enzyme, which comprises contacting said enzyme with an effective amount of a compound having the following formula (I)
26
wherein
each of R1, R2 and R5 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino, C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl;
each of R3 and R4 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino, C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl, or
R3 and R4, taken together, represent a 5 or 6 membered fused ring system having the following formula
—Y—(y)—X—(x)—Z—
wherein
(iii) when X represents methylene, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z both represent oxygen (O) or sulphur (S);
(iv) when X represents CR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S), R represents hydrogen or C1-C6 alky optionally substituted with C1-C6 dialkylamino and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(iii) when X represents C—OR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(iv) when X represents C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(v) when X represents C—SR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vi) when X represents C═S, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vii) when X represents N, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(viii) when X represents O═C—C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z represent NR′ wherein R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(ix) when X represents RO—C—C═O, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(x) when X represents RO—C—C—OR, —(y)— represents a double bond, —(x)— represents a double bond, Y and Z are N, where R represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xi) when X represents CH2—CO, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR, Z represents NR′ and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xii) when X represents CH2—C—OR′, —(y)— represents a single bond, —(x)— represents a double bond, Y represents NR, Z represents N and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xiii) when X represents CO—CH2, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl; or
(xiv) when X represents R′O—C—CH2, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
R6 represents hydrogen, halogen, cyano, NRaRb in which each of Ra and Rb represents, independently, hydrogen, C1-C6 alkyl, C1-C4 acyl, aroyl, C1-C6 alkylsulfonyl or arylsulfonyl;
each of R7 and R8 represents, independently, hydrogen, halogen, cyano, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, hydroxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, alkyl C1-C6 diarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl;
each of R9 and R10 represents, independently, hydrogen; C1-C6 alkyl unsubstituted or substituted by aryl;
C1-C6 acyl; aroyl; C1-C6 trialkylsilyl; aryl C1-C6 dialkylsilyl; C1-C6 alkyldiarylsilyl; triarylsilyl;
C1-C6 alkoxycarbonyl; or R9 and R10, taken together, represent methylene or carbonyl;
or a pharmaceutically acceptable salts thereof.

### Claim 2 (depends on 1)

A method for treating a telomerase-modulated disease, which comprises administering to a mammal a therapeutic effective amount of a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof.

### Claim 3 (depends on 1)

A method for treating a cancer disease related to a deranged cancer cell growth mediated by telomerase enzyme activity, which comprises administering to a mammal a therapeutic effective amount of a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof.

### Claim 4 (depends on 1)

A method for treating a cancer, which comprises administering to a mammal a therapeutic effective amount of a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof.

### Claim 5 (depends on 1)

A compound of formula (I) as defined in claim 1, for use in the preparation of a medicament having anticancer activity.

### Claim 6 (depends on 1)

A pharmaceutical formulation for treating a telomerase-modulated disease, which comprises a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 7 (depends on 1)

A pharmaceutical formulation for treating a cancer disease related to a deranged cancer cell growth mediated by telomerase enzyme activity, which comprises a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 8 (depends on 1)

A pharmaceutical formulation for treating a cancer, which comprises a compound of formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 9

A compound of formula (Ia)
27
wherein
R6 represents halogen, cyano, NRaRb in which each of Ra and Rb represents, independently, hydrogen, C1-C6 alkyl, C1-C4 acyl, aroyl, C1-C6 alkylsulfonyl or arylsulfonyl;
each of R3, R4 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl, or
R3 and R4, taken together, represent a 5 or 6 membered fused ring system having the following formula
—Y—(y)—X—(x)—Z—
wherein
(iv) when X represents methylene, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z both represent oxygen (O) or sulphur (S);
(v) when X represents CR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S), R represents hydrogen or C1-C6 alky optionally substituted with C1-C6 dialkylamino and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(iii) when X represents C—OR , —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(iv) when X represents C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(v) when X represents C—SR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vi) when X represents C═S, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vii) when X represents N, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(viii) when X represents O═C—C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z represent NR′ wherein R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(ix) when X represents RO—C—C═O, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(x) when X represents RO—C—C—OR, —(y)— represents a double bond, —(x)— represents a double bond, Y and Z are N, where R represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xi) when X represents CH2—CO, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR, Z represents NRI and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xii) when X represents CH2—C—OR′, —(y)— represents a single bond, —(x)— represents a double bond, Y represents NR, Z represents N and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xiii) when X represents CO—CH2, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl; or
(xiv) when X represents R′O—C—CH2, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl, or arylaminosulfonyl;
each of R7 and R8 represents, independently, hydrogen, halogen, cyano, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfony or arylaminosulfonyl;
each of R9 and R10 represents, independently, hydrogen, C1-C6 alkyl unsubstituted or substituted by aryl; C1-C6 acyl; aroyl; C1-C6 trialkylsilyl; aryl C1-C6 dialkylsilyl; C1-C6 alkyldiarylsilyl; triarylsilyl, C1-C6 alkoxycarbonyl; or R9 and R10, taken together, represents methylene or carbonyl;
or a pharmaceutically acceptable salt thereof.

### Claim 10

A compound of formula (Ib)
28
wherein:
R6 is hydrogen;
R3 and R4, taken together, represent a 5 or 6 membered fused ring system having the following formula
—Y—(y)—X—(x)—Z—
wherein
(ii) when X represents CR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S), R represents hydrogen or C1-C6 alky optionally substituted with C1-C6 dialkylamino and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(iii) when X represents C—OR , —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(iv) when X represents C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl, or C1-C6 acyl;
(v) when X represents C—SR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vi) when X represents C═S, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(vii) when X represents N, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(viii) when X represents O═C—C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z represent NR′ wherein R′ represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(ix) when X represents RO—C—C═O, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(x) when X represents RO—C—C—OR, —(y)— represents a double bond, —(x)— represents a double bond, Y and Z are N, where R represents hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xi) when X represents CH2—CO, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR, Z represents NR′ and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xii) when X represents CH2—C—OR′, —(y)— represents a single bond, —(x)— represents a double bond, Y represents NR, Z represents N and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
(xiii) when X represents CO—CH2, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl; or
(xv) when X represents R′O—C—CH2, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR and each of R and R′ represents, independently, hydrogen, C1-C6 alkyl or C1-C6 acyl;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl;
each of R7 and R8 represents, independently, hydrogen, halogen, cyano, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl, or arylaminosulfonyl;
each of R9 and R10 represents, independently, hydrogen; C1-C6 alkyl unsubstituted or substituted by an aryl; C1-C6 acyl; aroyl; C1-C6 trialkylsilyl; aryl C1-C6 dialkylsilyl; C1-C6 alkyldiarylsilyl; triarylsilyl; C1-C6 alkoxycarbonyl; or R9 and R10, taken together, represent methylene or carbonyl;
or a pharmaceutically acceptable salt thereof.

### Claim 11

A compound of formula (Ic)
29
wherein
R6 is hydrogen;
each of R3 and R4 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, arylC1-C6di alkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino arylsulfonylamino, C1-C6 alkylaminosulfonyl, and arylaminosulfonyl;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryldi C1-C6 alkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl;
each of R7 and R8 represents, independently, halogen, cyano, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl, or arylaminosulfonyl, provided that R7 and R8 are not contemporarily hydrogen;
each of R9 and R10 represents, independently, hydrogen, C1-C6 alkyl unsubstituted or substituted by an aryl, C1-C6 acyl, aroyl, C1-C6 trialkylsilyl, aryl C1-C6 di alkylsilyl, C1-C6 alkyldiarylsilyl, triarylsilyl or C1-C6 alkoxycarbonyl, or R9 and R10 taken together, represent methylene or a carbonyl;
or a pharmaceutically acceptable salt thereof.

### Claim 12 (depends on 9)

A compound of formula (Ia) according to claim 9 wherein
R6 is as defined in claim 9;
each of R3 and R4 represents, independently, hydrogen, halogen, cyano, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy, aroyloxy, C1-C6 trialkylsilyloxy, aryl C1-C6 dialkylsilyloxy, C1-C6 alkyldiarylsilyloxy, triarylsilyloxy, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl or arylaminosulfonyl, or
R3 and R4, taken together, represent a 5 or 6 membered fused ring system having the following formula
—Y—(y)—X—(x)—Z—
wherein
(i) when X represents methylene, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z both represent oxygen (O) or sulphur (S);
(vi) when X represents CR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S), R represents hydrogen or C1-C6 alky optionally substituted with C1-C6 dialkylamino and R′ represents hydrogen or C1-C6 alkyl;
(iii) when X represents C—OR , —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(iv) when X represents C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen or C1-C6 alkyl;
(v) when X represents C—SR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(vi) when X represents C═S, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen or C1-C6 alkyl;
(vii) when X represents N, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and R′ represents hydrogen or C1-C6 alkyl;
(viii) when X represents O═C—C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z represent NR′ wherein R′ represents hydrogen or C1-C6 alkyl;
(ix) when X represents RO—C—C═O, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(x) when X represents RO—C—C—OR, —(y)— represents a double bond, —(x)— represents a double bond, Y and Z represent N and R represents hydrogen or C1-C6 alkyl;
(xi) when X represents CH2—CO, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR, Z represents NR′ and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(xii) when X represents CH2—C—OR′, —(y)— represents a single bond, —(x)— represents a double bond, Y represents NR, Z represents N and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(xiii) when X represents CO—CH2, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl; or
(xiv) when X represents R′O—C—CH2, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy or aroyloxy; each of R7 and R8 represents, independently, hydrogen or halogen;
each of R9 and R10 represents, independently, hydrogen; C1-C6 alkyl unsubstituted or substituted by aryl; C1-C6 acyl; aroyl; or R9 and R10, taken together, represent methylene;
or a pharmaceutically acceptable salt thereof.

### Claim 13 (depends on 10)

A compound of formula (Ib) according to claim 10 wherein
R6 is as defined in claim 10;
R3 and R4, taken together, represent a 5 or 6 membered fused ring system having the following formula
—Y—(y)—X—(x)—Z—
wherein
(ii) when X represents CR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S), R represents hydrogen or C1-C6 alky optionally substituted with C1-C6 dialkylamino and R′ represents hydrogen or C1-C6 alkyl;
(iii) when X represents C—OR , —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(iv) when X represents C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen or C1-C6 alkyl;
(v) when X represents C—SR, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′, oxygen (O) or sulphur (S) and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(vi) when X represents C═S, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR′, oxygen (O) or sulphur (S) and R′ represents hydrogen or C1-C6 alkyl;
(vii) when X represents N, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and R′ represents hydrogen or C1-C6 alkyl;
(viii) when X represents O═C—C═O, —(y)— represents a single bond, —(x)— represents a single bond, Y and Z represent NR′ wherein R′ represents hydrogen or C1-C6 alkyl;
(ix) when X represents RO—C—C═O, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR′ and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(x) when X represents RO—C—C—OR, —(y)— represents a double bond, —(x)— represents a double bond, Y and Z represent N and R represents hydrogen or C1-C6 alkyl;
(xi) when X represents CH2—CO, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR, Z represents NR′ and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(xii) when X represents CH2—C—OR′, —(y)— represents a single bond, —(x)— represents a double bond, Y represents NR, Z represents N and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
(xiii) when X represents CO—CH2, —(y)— represents a single bond, —(x)— represents a single bond, Y represents NR′, Z represents NR and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl; or
(xiv) when X represents R′O—C—CH2, —(y)— represents a double bond, —(x)— represents a single bond, Y represents N, Z represents NR and each of R and R′ represents, independently, hydrogen or C1-C6 alkyl;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy or aroyloxy;
each of R7 and R8 represents, independently, hydrogen or halogen;
each of R9 and R10 represents, independently, hydrogen; C1-C6 alkyl unsubstituted or substituted by aryl; C1-C6 acyl; aroyl; or R9 and R10, taken together, represent methylene;
or a pharmaceutically acceptable salt thereof.

### Claim 14 (depends on 11)

A compound of formula (Ic) according to claim 11 wherein
R6 is as defined in claim 11;
each of R1, R2 and R5 represents, independently, hydrogen, halogen, hydroxy, C1-C6 alkoxy, C1-C6 acyloxy or aroyloxy;
each of R7 and R8 represents, independently, halogen, cyano, C1-C6 alkoxycarbonyl, carboxyl, nitro, amino, C1-C6 monoalkylamino C1-C6 dialkylamino, C1-C6 trialkylammonium halides, C1-C4 acylamino, aroylamino, C1-C6 alkylsulfonylamino, arylsulfonylamino, C1-C6 alkylaminosulfonyl, or arylaminosulfonyl, provided that R7 and R8 are not contemporarily hydrogen;
each of R9 and R10 represents, independently, hydrogen; C1-C6 alkyl unsubstituted or substituted by aryl; C1-C6 acyl; aroyl; or R9 and R10, taken together, represent methylene,
or a pharmaceutically acceptable salt thereof.

### Claim 15

A compound selected from the group consisting of:
3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 37);
3-chloro-2-(3,4-dimethoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 38);
3-cyano-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 39);
3-cyano-2-(3,4-dimethoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 40);
3-fluoro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 41);
2-(3,4-dimethoxyphenyl)-3-fluoro-7,8-dimethoxy-4H-chromen-4-one (compound 42);
2-(4-fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one(compound 43);
2-(3-fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one(compound 44);
2-(3-chlorophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 45);
2-(3,4-dichlorophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 46);
5-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 47);
5-chloro-2-(3,4-dimethoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 48);
6-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 49);
6-chloro-2-(3,4-dimethoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 50);
2-(3,4-diaminophenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 51);
2-(3,4-diaminophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 52);
N-[4-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)-2-nitrophenyl]acetamide (compound 53);
2-(4-acetylamino-3-nitrophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 54);
2-(4-amino-3-nitrophenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 55);
2-(4-amino-3-nitrophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 56);
2-(3,4-diacetylaminophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 57);
N-[2-(acetylamino)-4-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)phenyl]acetamide (compound 58);
2-(3,4-di-trifluoroacetylaminophenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 59);
2-(3,4-di-trifluoroacetylaminophenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 60);
2-(1H-benzimidazol-5-yl)-7,8-dimethoxy-4H-chromen-4-one (compound 61);
2-(1H-benzimidazol-5-yl)-7,8-dihydroxy-4H-chromen-4-one (compound 62);
2-(1H-benzimidazol-5-yl)-8-hydroxy-7-methoxy-4H-chromen-4-one (compound 63);
4-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)benzoic acid (compound 64);
2-(1H-1,2,3-benzotriazol-5-yl)-7,8-dimethoxy-4H-chromen-4-one (compound 65);
2-(1H-1,2,3-benzotriazol-5-yl)-7,8-dihydroxy-4H-chromen-4-one (compound 66);
5-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)-1,3-dihydro-2H-benzimidazol-2-one (compound 67);
5-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)-1,3-dihydro-2H-benzimidazol-2-one (compound 68);
7,8-dimethoxy-2-(2-sulfanyl-1H-benzimidazol-5-yl)-4H-chromen-4-one (compound 69);
7,8-dihydroxy-2-(2-sulfanyl-1H-benzimidazol-5-yl)-4H-chromen-4-one (compound 70);
2-(2-amino-1H-benzimidazol-5-yl)-7,8-dimethoxy-4H-chromen-4-one (compound 71);
2-(2-amino-1H-benzimidazol-5-yl)-7,8-dihydroxy-4H-chromen-4-one (compound 72);
2-(1,3-benzoxazol-5-yl)-7,8-dimethoxy-4H-chromen-4-one (compound 73);
2-(1,3-benzoxazol-5-yl)-7,8-dihydroxy-4H-chromen-4-one (compound 74);
2-(1,3-benzothiazol-5-yl)-7,8-dimethoxy-4H-chromen-4-one (compound 75);
2-(1,3-benzothiazol-5-yl)-7,8-dihydroxy-4H-chromen-4-one (compound 76);
2-(2, 4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 77);
8-hydroxy-7-methoxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one (compound 78);
7,8-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one (compound 79);
7,8-dimethoxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one (compound 80);
6-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)-1,4-dihydro-2,3-quinoxalinedione (compound 81);
6-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)-1,4-dihydro-2,3-quinoxalinedione (compound 82);
6-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)-3,4-dihydro-2(1H)-quinoxalinone (compound 83);
6-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)-3,4-dihydro-2(1H)-quinoxalinone (compound 84);
7-(7,8-dimethoxy-4-oxo-4H-chromen-2-yl)-3,4-dihydro-2(1H)-quinoxalinone (compound 85);
7-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)-3,4-dihydro-2(1H)-quinoxalinone (compound 86);
7,8-dimethoxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one (compound 87);
2-(2,4-dimethoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 88);
4-(7,8-dihydroxy-4-oxo-4H-chromen-2-yl)benzonitrile (compound 89);
2-(3,4-diacetoxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 90);
7,8-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-chromen-4-one (compound 91);
2-(3,4-dihydroxyphenyl)-7-hydroxy-8-methoxy-4H-chromen-4-one (compound 92);
7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-4H-chromen-4-one (compound 93);
7-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-8-methoxy-4H-chromen-4-one (compound 94);
8-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-chromen-4-one (compound 95);
8-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-4H-chromen-4-one (compound 96);
2-(3-hydroxy-4-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 97);
2-(3-fluoro-4-hydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 98);
2-(4-fluoro-3-hydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one (compound 99);
2-(3-hydroxy-4-methoxyphenyl)-7,8-dimethoxy-4H-chromen-4-one (compound 100);
7,8-dimethoxy-2-(2-methyl-1H-benzimidazol-5-yl)-4H-chromen-4-one (compound 101);
7,8-dihydroxy-2-(2-methyl-1H-benzimidazol-5-yl)-4H-chromen-4-one (compound 102);
2-{2-[3-(Dimethylamino)propyl]-1H-benzimidazol-5-yl}-7,8-dimethoxy-4H-chromen-4-one (compound 103)
and, if the case, the pharmaceutically acceptable salts thereof.

### Claim 16 (depends on 9, 10, 11)

A pharmaceutical composition which comprises as an active agent a compound of formula (Ia) as described in claim 9 or a pharmaceutically acceptable salt thereof, a compound of formula (Ib) as described in claim 10 or a pharmaceutically acceptable salt thereof or a compound of formula (Ic) as defined in claim 11 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.

### Claim 17 (depends on 16)

A pharmaceutical composition according to claim 16, for use in the treatment of a telomerase-modulated disease.

### Claim 18 (depends on 16)

A pharmaceutical composition according to claim 16, for use in the treatment of a cancer disease related to a deranged cancer cell growth mediated by telomerase enzyme activity.

### Claim 19 (depends on 16)

A pharmaceutical composition according to claim 16, for use in the treatment of a cancer.
